2 results
Approved WMOPending
To show differences in uptake of Primovist between FNHs and hepatocellular adenomas on CT.
Approved WMOCompleted
Main objective is to evaluate the efficacy and safety of two (Part 1) different dosing regimen and of one dosing regimen (Part 2) of intravenous alteplase given for up to 5 days on top of standard of care (SOC) compared with SOC alone in ARDS…